There Are Multiple Ways to Treat R/R CLL or R/R MCL: What Would the Experts Do? Medscape 59:02 1 month ago 34 Скачать Далее
Umbralisib with ibrutinib in patients with R/R CLL or MCL VJHemOnc – Video Journal of Hematology & HemOnc 3:15 4 years ago 90 Скачать Далее
R/R CLL: combination therapy and tailored treatment VJHemOnc – Video Journal of Hematology & HemOnc 2:41 4 years ago 135 Скачать Далее
CLL: Optimal approaches for patients with deletion 17p HMP Education 21:05 7 years ago 1 659 Скачать Далее
Updates in CLL - 2023 Best of Hematology Conference Total Health | Oncology 51:26 1 year ago 4 632 Скачать Далее
Personalized Treatment With Emerging BTK Inhibitor Options in CLL/SLL and MCL PeerView Oncology 1:02:27 2 years ago 200 Скачать Далее
Part 2 - How do I use BTKi for CLL management? - Dr. Nitin Jain, USA MICE IDEAS 32:51 3 years ago 180 Скачать Далее
Minimal residual disease (MRD) in CLL: Is it clinically relevant? HMP Education 21:09 6 years ago 1 721 Скачать Далее
Dr. Balzarotti on Questions With Consolidation and Maintenance Therapy in R/R DLBCL OncLive 1:16 3 years ago 83 Скачать Далее
What’s New In Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma ExchangeCME 27:37 2 days ago 15 Скачать Далее
Do we really need to transplant young patients with mantle cell lymphoma? HMP Education 18:21 10 years ago 1 629 Скачать Далее
Efficacy of novel agents in r/r T pro-lymphocytic leukaemia. ecancer 5:53 6 years ago 669 Скачать Далее
Long-term follow-up of acalabrutinib in R/R mantle cell lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 0:55 5 years ago 161 Скачать Далее
Part 5 - Clinical World Experience with Acalabrutinib in management of R/R CLL - Prof. Paolo Ghia MICE IDEAS 21:57 3 years ago 36 Скачать Далее